Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s535244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Jiayu Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Mitophagy, Medicine, Chinese Traditional. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a malignant tumor of the liver. Treatment programs according to its physiological and pathological characteristics have reduced the number of new cases and deaths of HCC, but the morbidity and mortality are still high, posing a significant threat to human health. In recent years, the importance of mitophagy in the treatment of HCC has gradually been recognized. The activation of mitophagy inhibits the survival, proliferation and migration of HCC cells through a variety of pathways, promotes cell apoptosis, and can also reduce drug resistance, providing a new direction for the treatment of HCC. Studies have shown that Traditional Chinese medicine (TCM) monomers and their derivatives can improve the therapeutic efficacy of HCC and slow down disease progression by regulating mitophagy. This article summarizes the potential mechanism of mitophagy in the progression of HCC and comprehensively explores the potential of TCM monomers and their derivatives in the treatment of HCC, providing new perspectives and strategies for clinical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
- Department of Hepatology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
- School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, People's Republic of China.
Zitieren
APA
Zhu, J., Yin, S., Luo, S., Yu, F., & Sun, K. (2025). Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s535244
Vancouver
Zhu J, Yin S, Luo S, Yu F, Sun K. Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s535244
BibTeX
@article{Zhu2025,
author = {Zhu, Jiayu and Yin, Sihan and Luo, Shengping and Yu, Fei and Sun, Kewei},
title = {Traditional Chinese Medicine Monomers and Their Derivatives as a Promising Therapeutic Tool for Hepatocellular Carcinoma by Activation of Mitophagy},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s535244}
}
EUVIMED